RNS Number : 8855B
JPMorgan China Growth & Income PLC
02 October 2025
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN CHINA GROWTH & INCOME PLC

(the 'Company')

 

Compliance with the Market Abuse Regulation

 

 

Legal Entity Identifier: 549300S8M91P5FYONY25

Information disclosed in accordance with the Market Abuse Regulation ('MAR')

 

 

The Company announces that it is satisfied that all inside information which the Directors and the Company may have, in the period leading up to the announcement of its annual financial results for the year ended 30th September 2025, has previously been, and will continue to be, notified to the London Stock Exchange ('LSE') via a regulatory information service. Therefore, the Company is not prohibited from dealing in its own securities.

 

The mandatory closed period under MAR will commence on 24th October 2025 and will last until the annual financial results in respect of the year ended 30th September 2025 are published, which is expected on or around 9th December 2025.

 

If, in the period leading up to the announcement of the annual financial results, the Directors of the Company come into the possession of any inside information, this will be notified to the LSE without delay and before any such transactions are undertaken.

 

 

 

JPMorgan Funds Limited - Company Secretary

2nd October 2025

 

 

For further information, please contact:

 

JPMorgan Funds Limited

Tel: 0800 20 40 20 (or +44 1268 44 44 70)

E-mail: [email protected]

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUUUVRVUURRAA